Research Analysts Set Expectations for ETON Q3 Earnings
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) – B. Riley lifted their Q3 2025 earnings per share (EPS) estimates for Eton Pharmaceuticals in a research note issued to investors on Wednesday, March 19th. B. Riley analyst M. El-Saadi now forecasts that the company will post earnings of $0.14 per share for the quarter, up from […]
